Griffon Corp (GFF) Chairman of the Board and CEO Ronald J Kramer Sold $10.8 million of Shares (Guru Focus)
Chairman of the Board and CEO of Griffon Corp, Ronald J Kramer, sold 500,000 shares of GFF on 08/21/2020 at an average price of $21.5 a share. The total sale was $10.8 million. Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals.
Wednesday 8/26 Insider Buying Report: JBGS, CNSP (Nasdaq.com)
On Monday, JBG SMITH Properties’ Director, Robert Alexander Stewart, made a $1.00M purchase of JBGS, buying 36,500 shares at a cost of $27.52 each. So far Stewart is in the green, up about 1.8% on their purchase based on today’s trading high of $28.03. JBG SMITH Properties is trading down about 0.1% on the day Wednesday. This purchase marks the first one filed by Stewart in the past year. And also on Monday, Chief Financial Officer Christopher Downs purchased $289,680 worth of CNS Pharmaceuticals, purchasing 142,000 shares at a cost of $2.04 a piece. CNS Pharmaceuticals is trading up about 17.4% on the day Wednesday. Downs was up about 39.7% on the buy at the high point of today’s trading session, with CNSP trading as high as $2.85 in trading on Wednesday.
What Did This CEO Just Do with Personal Shares of Trico Bancshares (NASDAQ: TCBK)? (Analyst Ratings)
Yesterday, the CEO & President of Trico Bancshares (TCBK), Richard P. Smith, sold shares of TCBK for $853.2K. This is Smith’s first Sell trade following 6 Buy transactions. The company has a one-year high of $41.42 and a one-year low of $23.05. Currently, Trico Bancshares has an average volume of 56.92K. TCBK’s market cap is $856 million and the company has a P/E ratio of 12.20.
Pharma Founder Charged In Insider Trading Case Over $3.5 Billion Sale To Teva (Forbes)
U.S. prosecutors on Tuesday announced fraud charges against Sepehr Sarshar, the 53-year-old founder of a California pharmaceutical company who the government says alerted his friends and family that his company was being purchased by pharma giant Teva in 2015 before the deal was announced, enabling them to allegedly reap $700,000 in profits on stock trades.
1life Healthcare Inc (ONEM) Chair, CEO and President Amir Dan Rubin Sold $7.8 million of Shares (Guru Focus)
Chair, CEO and President of 1life Healthcare Inc., Amir Dan Rubin, sold 266,945 shares of ONEM on 08/24/2020 at an average price of $29.39 a share. The total sale was $7.8 million. 1Life Healthcare Inc has a market cap of $3.57 billion; its shares were traded at around $28.30 with and P/S ratio of 9.94.